Steinberg Valentino Group is a SCAM. The one man show orchestrated by Ben Steinberg.

The Scammers ask, "Has your smallcap company struggled to find investors? You need a strong investor relations firm and SteinbergValentino Group can drive immediate results. Our IR firm can help immediately drive liquidity, price appreciation and find institutional investors."

The Extortion begins.

First Ben Steinberg makes promises and brilliantly explains the plan and execution.

After a miserable failure, Steinberg Valentino Group (or the one man show) Ben Steinberg begins to spin lies.

Next he demands payment (for nothing).

Finally when the company declines to pay for false promises he begins to post negative publicity and numerous lies.

If you want to avoid Ben Steinberg, President of Steinberg Valentino Group, simply ask for a video call and he will decline. Check the NYC address, 100 Church Street, Suite 8010, Manhattan, New York, 10007 and call the phone numbers listed.

Resolution Minerals Ltd (ASX: RML; OTCQB: RLMLF) is pleased to announce it has successfully uplisted to the OTCQB® Market in the U.S., commencing trading under ticker code RLMLF. 🇺🇸

🔹 Key Highlights

Commenced trading on OTCQB, upgrading from OTC Pink 🏦

Significantly expands visibility and access for U.S. retail & institutional investors

Provides exposure alongside U.S.-listed critical metals peers: MP Materials (NYSE: MP), Perpetua Resources (NASDAQ: PPTA), Critical Metals Corp (NASDAQ: CRML), NioCorp Developments (NASDAQ: NB)

Non-dilutive uplisting – no new shares issued, no capital raising

Supports U.S. DoD funding opportunities & fast-track permitting initiatives for critical minerals

Positioned for potential U.S. partnerships, acquisitions, and JVs

📍 Investor Outlook

With shares trading at A$0.060, RML offers investors dual-market exposure via the ASX and OTCQB, enhancing liquidity and accessibility. The Horse Heaven Antimony-Gold Project in Idaho sits strategically beside Perpetua Resources’ Stibnite Antimony-Gold Mine — positioning RML to benefit from increasing U.S. investor appetite for antimony, a critical mineral essential for defence, semiconductors, and clean energy technologies.

💬 Board Comment:

“This milestone uplisting reflects our commitment to broadening Resolution’s U.S. investor base while aligning with America’s strategic focus on secure critical mineral supply chains.”

📌 Investor Note

RML shares remain actively traded on both the ASX (RML) and OTCQB (RLMLF), with drilling underway at Horse Heaven.

Blockmate Ventures (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) is excited to welcome Tony G, a visionary blockchain investor, as a strategic partner in Hivello!

🔹 Hivello simplifies Decentralized Physical Infrastructure Networks (DePIN), enabling users to monetize idle computing power effortlessly. 🔹 Tony G’s backing reinforces DePIN as a major growth sector in Web3. 🔹 This follows his C$1.4M investment in Blockmate Ventures in December.

💬 “Hivello is bridging complex infrastructure with everyday users, unlocking massive potential in the decentralized economy.” – Tony G

📈 Investor Outlook:

Blockmate Ventures stock (TSX.V: MATE) is up 393.75% YoY and currently trading at C$0.22, reflecting strong investor confidence in its high-growth strategy across blockchain, AI, and renewable energy. With Tony G’s investment, Hivello is well-positioned to capitalize on the rising demand for DePIN solutions, further strengthening Blockmate’s market value.

🔗 Read more: https://stockhouse.com/news/the-market-online-news/2025/02/14/blockmate-ventures-hivello-secures-investment-from-tony-g

ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, is pleased to announce a definitive purchase agreement to acquire Datrix, LLC (Datrix), a global ambulatory device manufacturer based in Escondido, California. Datrix brings to CBSC a diversely experienced team of highly qualified individuals with extensive knowledge of design and engineering related to medical devices utilized in this ever-expanding market. Under the terms of the acquisition agreement, Datrix will continue to operate as an OEM manufacturer to its existing customer base and also become the exclusive manufacturer for the next generation of CBSC’s proprietary FDA- and CE-cleared ECG my-Cam Cardiac Event Monitor, including the interactive cloud-based My-Cardia acquisition software and the associated smartphone apps. This acquisition also provides CBSC and its subsidiary My-Cardia (USA) Inc.